Skip to main content

Neus Bellera Gotarda

Institutions of which they are part

Cardiovascular Diseases
Vall Hebron Institut de Recerca

Neus Bellera Gotarda

Institutions of which they are part

Cardiovascular Diseases
Vall Hebron Institut de Recerca

Projects

Patologia Cardiocirculatòria (GRC)

IP: -
Collaborators: Ignacio Ferreira González, José Antonio Barrabés Riu, Jose Fernando Rodríguez Palomares, Laura Gutierrez García-Moreno, Antonia Sambola Ayala, Nuria Rivas Gandara, Jordi Perez Rodon, Angeles Rojas Lopez, Antonio Rodríguez Sinovas, Joan Castell Conesa, Elsa Nieto Santa, Josep Pinar Sopena, Teresa González Alujas, Gisela Teixido Tura, Antonia Pijuan Domenech, Enric Domingo Ribas, Aida Ribera Sole, Rosa María Lidón Corbi, Francesc Xavier Armengol Castells, Gerard Marti Aguasca, Neus Bellera Gotarda, Imanol Otaegui Irurueta, Ignasi Barba Vert, Jordi Bañeras Rius, Bruno García del Blanco, Pilar Tornos Mas, Elisabet Miro Casas, Marisol Ruiz Meana, Mireia Andres Villarreal, Javier Inserte Igual, Laura Dos Subirá
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 65000
Reference: 2014 SGR 1572
Duration: 01/01/2014 - 31/12/2016

Terapia combinada con condicionamiento isquémico remoto y tratamiento metabólico para la prevención del daño por reperfusión en el infarto de miocardio. Eficacia en pacientes diabéticos

IP: -
Collaborators: Angeles Rojas Lopez, Antonio Rodríguez Sinovas, Neus Bellera Gotarda, Mireia Andres Villarreal, Mª Ángeles Carmona Ramírez
Funding agency: Instituto de Salud Carlos III
Funding: 125235
Reference: PI14/01431
Duration: 01/01/2015 - 31/12/2017

Efecto de la infusión intracoronaria de Antafomir-p2a sobre la contractilidad, remodelado e insuficiencia cardíaca postinfarto en un modelo porcino de infarto agudo de miocardio

IP: Neus Bellera Gotarda
Collaborators: Antonio Rodríguez Sinovas
Funding agency: -Sociedad Española de Cardiologia
Funding: 10000
Reference: SEC-2013-03
Duration: 18/07/2012 - 18/07/2013

Preventing cardiovascular ischemic events and arresting their consequences in type 2 diabetic population: a multidisciplinary clinical and experimental approach

IP: -
Collaborators: Ignacio Ferreira González, José Antonio Barrabés Riu, Joan Montaner Villalonga, Immaculada Raurell Saborit, Joan López Hellin, Antonio González Fernández, Antonia Sambola Ayala, Joaquin Lopez Soriano, Anna Meseguer Navarro, Antonio Rodríguez Sinovas, Rafael Simó Canonge, Francesc Moreso Mateos, Cristina Hernández Pascual, Anna Penalba Morenilla, Maria Nieves Martell Pérez-Alcalde, Neus Bellera Gotarda, Natalia Ramos Terrades, Andreea Ciudin Mihai, Maria Mar Hernandez Guillamon, Meritxell Ibernon Vilaró, Ignasi Barba Vert, Jordi Bañeras Rius, Bruno García del Blanco, Daniel Serón Micas, María Eugenia Espinel Garuz, Marisol Ruiz Meana, Maria Pilar Delgado Martínez, Irina Betsabe Torres Rodriguez, Javier Inserte Igual, Anna Rosell Novel, Olga Simó Servat, Joan Genescà Ferrer, Mònica Pons Delgado, M Antonieta Azancot Rivero, Maria Nazarena Pizzi, M Antonieta Azancot Rivero
Funding agency: Instituto de Salud Carlos III
Funding: 825000
Reference: PIE13/00027
Duration: 01/01/2014 - 30/06/2018

Related news

The study, led by Vall d'Hebron, is the first in Spain to analyse the relationship between pregnancy complications and the risk of long-term cardiovascular diseases.

The consensus document is the result of multidisciplinary work that takes into account the risks associated with all stages of women's lives and the differences compared to men.

The study, which involved Vall d'Hebron, developed an action plan to efficiently allocate resources to patients most at risk of suffering this complication.

Related professionals

Elena Valdivia Garcia

Elena Valdivia Garcia

Predoctoral researcher
Transfusional Medicine
Read more
Iria Arrese Muñoz

Iria Arrese Muñoz

Predoctoral researcher
Translational Immunology
Read more
Jorge Lunar Roldarn

Jorge Lunar Roldarn

Research technician
Gene Therapy at Nervous System
Read more
Cristina Kirkegaard Biosca

Cristina Kirkegaard Biosca

Predoctoral researcher
Infectious Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.